EBITDA was up 14.8% and stood at ₹635 crore compared to ₹553.2 crore, indicating improved operational performance.
The 34.5% year on year increase in revenue to ₹390 crore from Indian operations was the main contributor to revenue growth.
Net Interest Income (NII) slightly reduced by 0.5% to ₹480 crore as against ₹482 crore in Q3 FY24
Gross booking revenue in Q3 FY25 was ₹2,148.9 crore, indicating demand in the travel sector remained strong.
Here are some of the stocks that may see significant price movement today.
EBITDA surged to ₹600.3 crore, up from a loss of ₹208.7 crore in the year-ago quarter, indicating better operational efficiency
Srini Pallia, CEO, and MD of Wipro stated that the company is delighted to welcome Amit Kumar to its leadership team.
The US market is a key growth driver for the company, accounting for almost 47% of Zydus Lifesciences' revenue.
Revenue fell by 2.6% year-on-year to ₹4,567.4 crore against ₹4,689.3 crore in Q3 FY24, indicating a marginal slowdown in business activity.
Following an inspection carried out from Nov 14-22 2024, the facility was cited as being ‘VAI’ (Voluntary Action Indicated).

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.